Mersana Therapeutics, Inc. Retained Earnings
Mersana Therapeutics, Inc. had Retained Earnings of -$951.52 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-14
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$951.52M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$943.97M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$919.68M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$895.55M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$951.52M 10-Q · filed 2025-11-14 |
| 2025-06-30 | -$943.97M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$919.68M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$895.55M 10-Q · filed 2025-11-14 |
| 2024-09-30 | -$881.44M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$869.93M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$845.67M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$826.36M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$806.82M 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$765.16M 10-Q · filed 2023-08-08 |
| 2023-03-31 | -$710.85M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$654.69M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$609.77M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$549.96M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$497.74M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$450.48M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$401.50M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$356.02M 10-Q · filed 2021-08-06 |
| 2021-03-31 | -$315.11M 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$280.42M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$251.57M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$229.09M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$209.30M 10-Q · filed 2020-05-08 |
| 2019-12-31 | -$192.37M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$176.13M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$159.34M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$142.26M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$164.17M 10-K · filed 2020-02-28 |
| 2018-09-30 | -$141.73M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$124.67M 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$112.31M 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$97.88M 10-K · filed 2019-03-08 |
| 2017-09-30 | -$83.91M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$76.18M 10-Q · filed 2017-08-11 |
| 2016-12-31 | -$59.17M 10-K · filed 2018-03-28 |